NEPT Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-0.2441|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-15.98M|
|Gross Profit Margin (Quarterly)||14.16%|
|Profit Margin (Quarterly)||-126.9%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM)||Upgrade|
Street Insider06/23 07:10
NEPT Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Neptune Technologies is down 49.76% over the last year vs S&P 500 Total Return up 19.14%, Enzymotec up N/A, and ARCA biopharma up 0.00%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for NEPT
Portfolio Strategies Featuring NEPT
Did Neptune Technologies make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.neptunebiotech.com
- IR Website: http://www.neptunebiotech.com/en/investors
- HQ Country: Canada
- HQ State/Province: Quebec
- Incorporation Country: Canada
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: May 31, 2014
- Est. Current Fiscal Year End: February 28, 2015
- Last Fiscal Quarter End: May 31, 2014
- Last Fiscal Year End: February 28, 2014
- NAICS: Biological Product (except Diagnostic) Manufacturing
- NAICS Code: 325414
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
Neptune Technologies & Bioressources Inc is a biotechnology company engaged in the development, manufacture and commercialization of marine‐derived omega‐3 polyunsaturated fatty acids.
NEPT Excel Add-In Codes
- Name: =YCI("NEPT","name")
- Description: =YCI("NEPT","description")
- Sector: =YCI("NEPT","sector")
- Industry: =YCI("NEPT","industry")
- Est. Current Fiscal Year End: =YCI("NEPT","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.